How much weight can you lose on 0.5mg Wegovy?

Free clinical consultation (no upfront fee to find out if you're suitable
Prescription written by a GPhC-registered Independent Prescriber who personally reviews your case the same day
Treatment, prescription, and free next-working-day tracked delivery by DPD) all in one transparent price
Priority aftercare seven days a week, with clinical re-review before every repeat order

At 0.5mg, Wegovy is a stepping-stone dose, not a treatment target — clinical trials tested the 2.4mg maintenance dose, where average weight loss reached around 15% of body weight over 68 weeks. How much weight you lose on 0.5mg specifically depends on where you are in the titration schedule and how long you stay there. Wegovy (semaglutide) is a prescription-only medicine, so the journey from this early dose toward the maintenance level is guided by a prescriber who reviews your response and tolerance at each stage. For a full picture of what the evidence says at higher doses, our overview of Wegovy weight loss results walks through the trial data across the full schedule.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence and private pricing actually tell you at this stage of treatment

What the STEP 1 trial data can and can't tell you about 0.5mg

The landmark evidence for Wegovy comes from the STEP 1 trial, published in the New England Journal of Medicine, which followed adults with obesity over 68 weeks. Participants taking semaglutide 2.4mg alongside lifestyle support lost an average of around 15% of their body weight. That figure is widely quoted — and it applies to the maintenance dose, not 0.5mg.

The 0.5mg dose is the second rung of the titration ladder. Treatment starts at 0.25mg for four weeks to let the body adjust, and if you want to understand how much weight you can lose on 0.25mg Wegovy, that starting phase is worth reading about before considering what comes next. Then it moves to 0.5mg for a further four weeks before the prescriber considers stepping up. Its job is to reduce early nausea and settle the gut, not to produce the weight loss that happens at 1.7mg or 2.4mg. Some people do notice their appetite shifting even at this stage (slower gastric emptying is already active) but the clinical trial was not designed to measure weight loss at sub-therapeutic doses in isolation.

For context on how results change as the dose increases, the 1mg dose page sets out what happens at the next step, and the full picture at the standard maintenance level is covered in the 2.4mg results page. The honest answer to how much weight you lose on 0.5mg Wegovy is: it varies, it's early, and the prescriber's guidance on how long you stay there matters more than the number on the scale right now.

How private Wegovy pricing works, and what the 0.5mg period costs you

UK private pricing for Wegovy is structured per pen, per month, and varies between providers and by dose. Following Eli Lilly's list-price increase in September 2025 for tirzepatide, the wider market adjusted; Wegovy pricing from private providers typically falls in a range of roughly £149 to £375 per month, hedged by dose and supplier, as widely reported. The 0.5mg phase represents roughly weeks five to eight of treatment, so for most people it's a short window in a longer programme, worth understanding in context rather than in isolation.

What matters more than the per-pen figure is what any quoted price actually includes. Some providers list a medicine price and then add consultation fees, prescription charges, or delivery costs separately. Others charge for dose-review calls or ongoing clinical support as an add-on. When comparing costs, it takes under a minute to check whether a pharmacy appears on the GPhC register, that verification step costs nothing and tells you whether the dispensing pharmacy is properly regulated.

At nume, one transparent price covers the free consultation, the prescription, the treatment itself, and free next-working-day delivery by DPD. There are no subscription traps and no auto-renewals. Every repeat order goes back to a prescriber for clinical re-review. We're not the cheapest option (that's a deliberate choice) because the clinical infrastructure behind each order is part of what you're paying for. For a fuller breakdown of what Wegovy private treatment costs in the UK, the Wegovy price page covers the market context in detail.

Why 'cheapest' is the wrong question for a prescription medicine at any dose

Wegovy is a prescription-only medicine. That means the only legal route to it in the UK is a prescription issued following a proper clinical assessment, at 0.5mg, at 2.4mg, or anywhere on the schedule. The MHRA has warned publicly about counterfeit weight-loss pens sold online and via social media, some containing insulin rather than semaglutide, with real harm resulting. Prices far below the market range, sellers who don't ask for any clinical information, and "discount codes" offered by unverified accounts are all red flags worth taking seriously.

For a medicine that works by changing how your body handles appetite and digestion, the right questions are clinical ones: is this the right treatment for me, at this dose, given my health history? Anyone considering whether to move up the titration schedule may also find it useful to read about how much weight you can lose on Wegovy 1.7mg, since that dose sits just before the final maintenance step and gives a clearer sense of what the programme builds toward. Suspected counterfeit sellers can be reported at the MHRA's Yellow Card service. The Wegovy treatment page sets out how the full titration schedule works and what clinical oversight looks like at each stage.

If you're ready to find out whether Wegovy is clinically suitable for you, speak to our prescribers, the consultation is free, and a named clinician reviews it the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions